When a small molecule can cross the blood‑brain barrier, bind a disease‑causing protein with surgical precision, and do so without the safety concerns that have hamstrung previous attempts, the scientific community takes notice. SONE‑190, the lead candidate from , is generating that exact buzz. Early‑phase data suggest it could become the first disease‑modifying therapy for frontotemporal dementia (FTD) —a disorder that currently has no approved treatments and devastates patients and families within a few short years.
If you're installing this in an existing ceiling, check for attic access. High-CFM fans often require larger ducting (typically 6 inches) to maintain their low noise level and peak performance. SONE-190
While "SONE-190" isn't a single industry term, it likely refers to high-performance ventilation fans, specifically the . When a small molecule can cross the blood‑brain
refers to a specific essay titled Cyclic Repetition and Transferred Temporalities written by . It is the 14th chapter in the academic collection Performance and Temporalisation: Time Happens , starting on page 190. If you're installing this in an existing ceiling,